Holen Sie sich die Stockscreener-App
13.09
0.42%
-0.04
Schlusskurs vom Vortag:
$13.13
Offen:
$13.15
24-Stunden-Volumen:
264.55K
Relative Volume:
0.28
Marktkapitalisierung:
$1.02B
Einnahmen:
$1.53B
Nettoeinkommen (Verlust:
$40.23M
KGV:
26.18
EPS:
0.5
Netto-Cashflow:
$60.93M
1W Leistung:
+5.27%
1M Leistung:
-1.25%
6M Leistung:
+2.55%
1J Leistung:
-40.97%
1-Tages-Spanne:
$12.93
$13.27
1-Wochen-Bereich:
$11.86
$13.27
52-Wochen-Spanne:
$10.87
$27.13
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Firmenname
Integra Lifesciences Holdings Corp
Sektor
Branche
Telefon
(609) 275-0500
Adresse
1100 CAMPUS ROAD, PRINCETON, NJ
Vergleichen Sie IART mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
13.08 | 1.02B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
127.06 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.64 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.09 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.56 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.52 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Underweight |
| 2024-10-07 | Hochstufung | BTIG Research | Sell → Neutral |
| 2024-07-30 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-07-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-05-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-12-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Eingeleitet | CL King | Buy |
| 2023-08-24 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-08 | Herabstufung | Argus | Buy → Hold |
| 2023-05-24 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-25 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2021-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Eingeleitet | Citigroup | Neutral |
| 2020-04-03 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Eingeleitet | SunTrust | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-07 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-07-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Eingeleitet | UBS | Buy |
Alle ansehen
Integra Lifesciences Holdings Corp Aktie (IART) Neueste Nachrichten
Integra LifeSciences to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire
3 Reasons to Sell IART and 1 Stock to Buy Instead - Finviz
Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive Officer - Quantisnow
At US$12.66, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely? - Yahoo Finance
Will Integra LifeSciences Holdings Corporation stock keep outperforming rivalsTrade Exit Summary & Real-Time Volume Triggers - Улправда
What Wall Street predicts for Integra LifeSciences Holdings Corporation stock price - Улправда
How geopolitical tensions affect Integra LifeSciences Holdings Corporation stockMarket Growth Summary & Weekly Return Optimization Plans - Улправда
How buybacks impact Integra LifeSciences Holdings Corporation stock valueQuarterly Earnings Summary & Consistent Income Trade Recommendations - DonanımHaber
How Integra LifeSciences Holdings Corporation (IL3) stock reacts to fiscal policiesJuly 2025 Price Swings & Low Drawdown Momentum Trade Ideas - ulpravda.ru
Why Integra LifeSciences Holdings Corporation stock is considered a top pickPortfolio Update Summary & Fast Gaining Stock Reports - DonanımHaber
How supply shortages influence Integra LifeSciences Holdings Corporation (IL3) stockWeekly Profit Summary & Long-Term Capital Growth Ideas - Улправда
Is Integra LifeSciences Holdings Corporation stock resilient to inflation2025 Key Highlights & Community Verified Watchlist Alerts - Улправда
What valuation multiples suggest for Integra LifeSciences Holdings Corporation stockJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - DonanımHaber
Why Integra LifeSciences Holdings Corporation (IL3) stock is favored by hedge fundsWeekly Market Report & Consistent Profit Alerts - DonanımHaber
Why Integra LifeSciences Holdings Corporation stock could outperform in 2025 - Улправда
Will Integra LifeSciences Holdings Corporation stock maintain dividend yield2025 Volume Leaders & High Yield Equity Trading Tips - Улправда
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Given Consensus Rating of "Reduce" by Brokerages - MarketBeat
Integra LifeSciences Holdings (NASDAQ:IART) Nasdaq Index Procedural Tools - Kalkine Media
Is Integra LifeSciences (IART) Undervalued After Its Recent Share Price Rebound? - simplywall.st
Integra LifeSciences (NASDAQ: IART) adopts renewed CIC severance plan - Stock Titan
Holdings of Integra Lifesciences Holdings Corp (IART) are aligned with the stars - setenews.com
How Integra LifeSciences Holdings Corporation (IL3) stock responds to bond marketWeekly Trade Summary & Accurate Entry and Exit Point Alerts - Newser
Will Integra LifeSciences Holdings Corporation (IL3) stock test record highs in 2025Forecast Cut & AI Based Buy and Sell Signals - Newser
Adversity is less terrifying than hope: Integra Lifesciences Holdings Corp (IART) - Setenews
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference - The Manila Times
Integra LifeSciences (Nasdaq: IART) slated for Citi 2025 Global Healthcare Conference - Stock Titan
How does Integra Lifesciences Holdings Corp (IART) change from a tortoise to a hare? - Setenews
A Fresh Look at Integra LifeSciences (IART) Valuation After Recent Share Price Volatility - Yahoo Finance
Why Integra LifeSciences Holdings (IART) Is Up 17.7% After Medicare Expands Reimbursement for Skin Substitutes - simplywall.st
Integra LifeSciences Drops After Cutting Revenue Outlook - Finimize
Integra LifeSciences (IART) Welcomes CMS Inclusion of Key Produc - GuruFocus
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access - Finviz
Integra LifeSciences Applauds CMS Ruling on Medicare Payment Schedule Benefiting Skin Substitute Products - Quiver Quantitative
Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know - Yahoo Finance
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat
Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know - Barchart.com
How robust is Integra LifeSciences Holdings Corporation (IL3) stock financial positionAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Why Integra LifeSciences Holdings Corporation stock is recommended by analystsEarnings Summary Report & Weekly Stock Performance Updates - newser.com
Is Integra LifeSciences Holdings Corporation (IL3) stock vulnerable to rate hikes - newser.com
Prepare Yourself for Liftoff: Acadia Healthcare Company Inc (ACHC) - setenews.com
How institutional ownership impacts Integra LifeSciences Holdings Corporation stock2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com
Is Integra LifeSciences Holdings Corporation stock cheap at current valuation2025 Bull vs Bear & Safe Swing Trade Setups - newser.com
Does Integra LifeSciences Holdings Corporation show high probability of reboundJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
How buyback programs support Integra LifeSciences Holdings Corporation (IL3) stockTrade Analysis Report & Risk Managed Investment Signals - newser.com
FDA Grants 510(k) Clearance to Ultrasonic Surgical Aspirator System for Cardiac Surgeries - Diagnostic and Interventional Cardiology
Surgical Equipment & ConsumablesSpecialty Stocks Q3 Recap: Benchmarking Integra LifeSciences (NASDAQ:IART) - Yahoo Finance
Is Integra LifeSciences Holdings Corporation stock vulnerable to regulatory risksJuly 2025 Summary & Verified Momentum Watchlists - newser.com
Is Integra LifeSciences Holdings Corporation stock a buy for dividend growthWeekly Trade Summary & Real-Time Buy Signal Notifications - newser.com
Finanzdaten der Integra Lifesciences Holdings Corp-Aktie (IART)
Umsatz
Nettogewinn
Free Cashflow
ENV
Integra Lifesciences Holdings Corp-Aktie (IART) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Oct 12 '25 |
Option Exercise |
0.00 |
11,965 |
0 |
25,217 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 11 '25 |
Option Exercise |
0.00 |
2,356 |
0 |
4,391 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '25 |
Option Exercise |
0.00 |
1,180 |
0 |
2,359 |
1.20%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):